Table of contents

ORIGINAL ARTICLES

• The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients (1 January, 2005)

  J. Rahaman, P. Dottino, T. S. Jennings, J. Holland, C. J. Cohen
• Clinical features of hepatic metastasis in patients with ovarian cancer (1 January, 2005)

  V. Loizzi, C. Rossi, G. Cormio, A. Cazzolla, D. Altomare, L. Selvaggi
• Pseudomyxoma peritonei: a case series and review of the literature (1 January, 2005)

  M. L. Hopkins, A. D. Depetrillo, T. Le, M. Fung Kee Fung
• Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546 (1 January, 2005)

  M. Saito, D. Aoki, N. Susumu, A. Suzuki, N. Suzuki, Y. Udagawa, S. Nozawa
• Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy (1 January, 2005)

  A. Kikuchi, H. Sakamoto, T. Yamamoto
• Characterization of differentially expressed genes in ovarian cancer by cDNA microarrays (1 January, 2005)

  X. Zhang, J. Feng, Y. Cheng, Y. Yao, X. Ye, T. Fu, H. Cheng
• Microvessel quantification in benign and malignant ovarian tumors (1 January, 2005)

  S. J. Amis, S. D. Coulter-Smith, J. C. Crow, A. B. Maclean, C. W. Perrett
• Effect of the sampling sequence on the quality of Papanicolaou smear (1 January, 2005)

  P. Rahnama, S. Faghihzadeh, S. Ziaei
• Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

  (1 January, 2005)

  N. Susumu, D. Aoki, T. Noda, Y. Nagashima, T. Hirao, Y. Tamada, K. Banno, A. Suzuki, N. Suzuki, H. Tsuda, J. Inazawa, S. Nozawa
• Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions (1 January, 2005)

  G.-Y. Lee, S.-M. Kim, S.-Y. Rim, H.-S. Choi, C.-S. Park, J.-H. Nam
• Prognostic factors in microinvasive cervical squamous cell cancer: long-term results (1 January, 2005)

  F. Raspagliesi, A. Ditto, P. Quattrone, E. Solima, R. Fontanelli, V. Dousias, S. Kusamura, M. L. Carcangiu
• Cellular process classification of human papillomavirus-16-positive SiHa cervical carcinoma cell using Gene Ontology (1 January, 2005)

  W. S. Ahn, M.-J. Seo, S. M. Bae, J. M. Lee, S. E. Namkoong, C. K. Kim, Y.-W. Kim
• Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women

  (1 January, 2005)

  S. Kang, Y. T. Jeon, J. W. Kim, N. H. Park, Y. S. Song, S. B. Kang, H. P. Lee
• Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors (1 January, 2005)

  J.-P. Lee, K.-H. Chang, J.-H. Han, H.-S. Ryu
• Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva (1 January, 2005)

  P. Stoltzfus, K. Heselmeyer-Haddad, J. Castro, N. White, C. Silfverswärd, K. Sjövall, N. Einhorn, K. Tryggvason, G. Auer, T. Ried, B. Nordström
• Which surgical procedure for patients with atypical endometrial hyperplasia? (1 January, 2005)

  B. S. Karamursel, S. Guven, G. Tulunay, T. Kucukali, A. Ayhan
• Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre (1 January, 2005)

  K.-L. J. Kelly, P. S. Craighead
• Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemical study of 12 cases (1 January, 2005)

  C. A. Amezcua, S. J. Begley, N. Mata, J. C. Felix, C. A. Ballard
• Profiling of differentially expressed genes in human uterine leiomyomas (1 January, 2005)

  E.-J. Lee, G. Kong, S.-H. Lee, S. B. Rho, C.-S. Park, B.-G. Kim, D.-S. Bae, J. J. Kavanagh, J.-H. Lee
• Loss of heterozygosity alterations associated with progesterone therapy in endometrial hyperplasia and adenocarcinoma (1 January, 2005)

  M. Yasuda, S. Kotajima, H. Kajiwara, S. Takekoshi, R. Y. Osamura, T. Yoshitake, T. Muramatsu, T. Miyamoto, M. Murakami, T. Shinozuka